Heers Hendrik, Boegemann Martin, Hegele Axel
Department of Urology und Pediatric Urology, Philipps University Marburg.
Department of Urology und Pediatric Urology, University Münster - Germany.
Aktuelle Urol. 2018 Feb;49(1):25-36. doi: 10.1055/s-0043-123706. Epub 2018 Feb 1.
In 2017, many new and promising therapeutic innovations entered uro-oncology. Immunotherapy was highly topical and was intensively discussed at the annual meetings. This review summarises the news, together with future developments in the diagnosis and treatment of prostate, bladder and kidney cancer. Within the last year, there have been major developments in the treatment of hormone sensitive metastastic prostate cancer, metastatic transitional cell carcinoma and metastastic renal cell cancer. Many new drugs will be added to our therapeutic arsenal during the upcoming months.
2017年，许多新的、有前景的治疗创新进入了泌尿肿瘤学领域。免疫疗法备受关注，并在年会上进行了深入讨论。本综述总结了前列腺癌、膀胱癌和肾癌诊断与治疗方面的新进展以及未来发展趋势。在过去一年里，激素敏感性转移性前列腺癌、转移性移行细胞癌和转移性肾细胞癌的治疗取得了重大进展。在接下来的几个月里，许多新药将被纳入我们的治疗手段。
